Status:
UNKNOWN
Description of Lung Transplant Patients With Microbiologically Documented Stenotrophomonas Maltophilia Pneumonia and Impact of Treatment on Outcome
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Transplantation Infection
Eligibility:
All Genders
18+ years
Brief Summary
Stenotrophomonas maltophilia is a multi-resistant Gram-negative bacillus and is an opportunistic pathogen. Stenotrophomonas maltophilia infections are associated with a significant morbidity and morta...
Eligibility Criteria
Inclusion
- Patient whose age ≥ 18 years
- Patient who has received a lung (mono or bi-pulmonary) or heart-lung transplant
- Patient with documented pneumopathy (clinico-radiological definition) (positive respiratory specimen for Stenotrophomonas maltophilia)
- French speaking patient
Exclusion
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under court protection
- Patient objecting to the use of his data for this research
Key Trial Info
Start Date :
November 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05193058
Start Date
November 22 2021
End Date
December 31 2023
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014